Minimally adjusted odds of incident SARS-CoV-2 infection
OR | 95% CI | P value | Group p value | |
Age (years) | 0.98 | 0.96 to 0.99 | <0.001 | |
Female biological sex | 0.94 | 0.63 to 1.39 | 0.76 | |
Race/ethnicity | ||||
White | Reference | 0.35* | ||
Black | 2.04 | 0.50 to 8.27 | 0.32 | 0.24† |
Hispanic (any race) | 1.2 | 0.61 to 2.39 | 0.59 | |
Asian or Pacific Islander | 0.18 | 0.02 to 1.26 | 0.08 | |
Other (including multiracial) | 1.22 | 0.39 to 3.85 | 0.73 | |
Highest level of education | ||||
Less than high school | Reference | <0.001* | ||
High school graduate | 0.91 | 0.11 to 7.44 | 0.93 | <0.001† |
Some college | 0.51 | 0.07 to 3.87 | 0.52 | 0.42‡ |
College graduate | 0.34 | 0.05 to 2.56 | 0.3 | |
Postgraduate | 0.2 | 0.03 to 1.51 | 0.12 | |
Other | 1.02 | 0.10 to 10.02 | 0.99 | |
MacArthur Subjective Social Status Ladder (per point on scale) | 0.87 | 0.79 to 0.96 | 0.004 | |
Working in healthcare | 1.66 | 1.09 to 2.50 | 0.017 | |
Medical comorbidities | ||||
Atrial fibrillation | 0.38 | 0.09 to 1.55 | 0.18 | |
Anaemia | 0.65 | 0.32 to 1.34 | 0.24 | |
Asthma | 0.78 | 0.40 to 1.55 | 0.48 | |
Coronary artery disease | 0.46 | 0.11 to 1.89 | 0.28 | |
Cancer | 0.96 | 0.39 to 2.34 | 0.92 | |
Congestive heart failure | 0.99 | 0.14 to 7.09 | 0.99 | |
COPD | 0.84 | 0.21 to 3.44 | 0.81 | |
Diabetes | 1.37 | 0.67 to 2.83 | 0.39 | |
Hypertension | 1.13 | 0.75 to 1.71 | 0.56 | |
HIV | 5.31 | 1.65 to 17.12 | 0.005 | |
Other immunodeficiency | 1.57 | 0.58 to 4.25 | 0.37 | |
History of heart attack | 1.16 | 0.28 to 4.73 | 0.84 | |
Sleep apnoea | 0.91 | 0.51 to 1.62 | 0.74 | |
History of stroke | 1 | 0.25 to 4.08 | 1 | |
Alcohol use | ||||
None | Reference | 0.25* | ||
>0–7 drinks per week | 0.95 | 0.60 to 1.51 | 0.83 | 0.13† |
>7–14 drinks per week | 1.01 | 0.55 to 1.84 | 0.97 | 0.047‡ |
>14 drinks per week | 0.13 | 0.02 to 0.95 | 0.044 | |
Smoking | ||||
Cigarette use in the last 30 days | 1.91 | 0.94 to 3.88 | 0.07 | |
E-cigarette use in the last 30 days | 2.98 | 1.64 to 5.41 | <0.001 | |
Marijuana use in the last 30 days | 1.03 | 0.56 to 1.84 | 0.93 | |
Mean sleep duration (per hour of sleep) | 1.13 | 0.86 to 1.49 | 0.37 | |
Living with children at home | 1.23 | 0.89 to 1.71 | 0.21 | |
Living with pets at home | 1.35 | 0.88 to 2.07 | 0.17 | |
Use of face masks, last 4–21 days | ||||
‘Never’ | Reference | |||
‘Sometimes’ | 1.15 | 0.50 to 2.61 | 0.74 | |
‘Most times’ or ‘Always’ | 1.11 | 0.45 to 2.72 | 0.82 | |
Handwashing frequency, last 4–21 days | ||||
<2 times/day | Reference | |||
2–4 times/day | 1.36 | 0.65 to 2.81 | 0.41 | |
5–10 times/day | 1.08 | 0.59 to 1.95 | 0.8 | |
>10 times/day | 1.5 | 0.81 to 2.77 | 0.2 | |
Exercise frequency, last 4–21 days | ||||
<1 time/month | Reference | |||
<1 time/week | 2.21 | 1.31 to 3.76 | 0.003 | |
Approximately weekly | 1.25 | 0.76 to 2.04 | 0.38 | |
2–4 days/week | 1.18 | 0.73 to 1.92 | 0.5 | |
>4 days/week | 0.91 | 0.51 to 1.64 | 0.76 | |
Number of contacts (per 10), last 4–21 days | 1.17 | 1.09 to 1.26 | <0.001 | |
Number of events with 10 or more people (per 10), last 4–21 days | 1.04 | 1.03 to 1.05 | <0.001 | |
Number of gym visits (per 10), last 4–21 days | 0.59 | 0.15 to 2.35 | 0.45 | |
Number of visits to movie theatres (per 10), last 4–21 days | 2.17 | 1.10 to 4.27 | 0.025 | |
Number of visits to restaurants (per 10), last 4–21 days | 2.06 | 1.57 to 2.70 | <0.001 |
Models were adjusted for age, sex, race/ethnicity and calendar date.
*Overall heterogeneity.
†Heterogeneity of non-reference levels.
‡Linear trend.
COPD, chronic obstructive pulmonary disease.